THE ANTIPROLIFERATIVE PROPERTIES OF TAMOXIFEN AND PHENOTHIAZINES MAY BE MEDIATED BY A UNIQUE HISTAMINE-RECEPTOR (QUESTIONABLE-H-3) DISTINCT FROM THE CALMODULIN-BINDING SITE

被引:36
作者
BRANDES, LJ
BOGDANOVIC, RP
CAWKER, MD
BOSE, R
机构
[1] UNIV MANITOBA,DEPT PHARMACOL,WINNIPEG R3E 0V9,MANITOBA,CANADA
[2] UNIV MANITOBA,MANITOBA INST CELL BIOL,WINNIPEG R3E 0V9,MANITOBA,CANADA
关键词
D O I
10.1007/BF00253057
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:21 / 23
页数:3
相关论文
共 18 条
[1]   A DIPHENYLMETHANE DERIVATIVE SELECTIVE FOR THE ANTI-ESTROGEN BINDING-SITE MAY HELP DEFINE ITS BIOLOGICAL ROLE [J].
BRANDES, LJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 124 (01) :244-249
[2]   A DIPHENYLMETHANE DERIVATIVE SPECIFIC FOR THE ANTIESTROGEN BINDING-SITE FOUND IN RAT-LIVER MICROSOMES [J].
BRANDES, LJ ;
HERMONAT, MW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 123 (02) :724-728
[3]   EVIDENCE THAT THE ANTIESTROGEN BINDING-SITE IS A HISTAMINE OR HISTAMINE-LIKE RECEPTOR [J].
BRANDES, LJ ;
MACDONALD, LM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 126 (02) :905-910
[4]   NEW EVIDENCE THAT THE ANTIESTROGEN BINDING-SITE MAY BE A NOVEL GROWTH-PROMOTING HISTAMINE-RECEPTOR (QUESTIONABLE-H-3) WHICH MEDIATES THE ANTIESTROGENIC AND ANTIPROLIFERATIVE EFFECTS OF TAMOXIFEN [J].
BRANDES, LJ ;
BOGDANOVIC, RP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 134 (02) :601-608
[5]  
GOTH A, 1973, HISTAMINE ANTIHISTAM, V1, P25
[6]   CHARACTERISTICS OF THE CYTO-TOXIC EFFECTS OF THE PHENOTHIAZINE CLASS OF CALMODULIN ANTAGONISTS [J].
HAIT, WN ;
LEE, GL .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (22) :3973-3978
[7]  
HAIT WN, 1985, CANCER CHEMOTH PHARM, V14, P202, DOI 10.1007/BF00258116
[8]  
KROEGER EA, 1985, BIOCH BIOPHYS RES CO, V126, P750
[9]   TAMOXIFEN IS A CALMODULIN ANTAGONIST IN THE ACTIVATION OF CAMP PHOSPHODIESTERASE [J].
LAM, HYP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 118 (01) :27-32
[10]   ANTIESTROGENIC EFFECT OF TRIFLUOPERAZINE IN MICE [J].
LYMAN, SD ;
JORDAN, VC .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (12) :2221-2224